Individuals under age 18 seeking weight management treatment should consult pediatric healthcare providers who specialize in adolescent medicine and metabolic health
Cost should not be a barrier to entry
While clinical trials for FDA approval for use of GLP-1/GIP medications in the treatment of T1D are ongoing, the consensus statement emphasizes several key principles for safe use in the meantime: Insulin safety comes first People with type 1 diabetes should never stop taking insulin while using a GLP-1 or GIP medication
In both these instances, conditions tend to improve due to body weight dropping making it important to recognise which benefits are due to weight loss rather than any specific pharmacological action
While traditionally applied in medicine, recent years have seen an increasing exploration of SRs in agronomic studies, particularly in elucidating plant-pathogen interaction mechanisms encompassing molecular, biological, and biochemical responses (Soares et al., 2021